Venrock Healthcare Capital Partners III, L.P.
10% Owner · Lycia Therapeutics, Inc.
Every open-market stock purchase Venrock Healthcare Capital Partners III, L.P. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- LYCALycia Therapeutics, Inc.
12 purchases totalling $38.5M at an average of $18.53 per share. See all insider buying in LYCA →
Avg price paid$18.53Latest price—Market capUnknown - KALVKalVista Pharmaceuticals, Inc.
2 purchases totalling $929.3K at an average of $9.26 per share. See all insider buying in KALV →
Avg price paid$9.26Latest price—Market cap$1.4B
Cluster participation
Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.
All reported buys
| Date | Ticker | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Nov 2, 2026 | 8,305 | $26.95 | $223.8K | SEC ↗ | |
| Oct 30, 2026 | 200 | $26.86 | $5.4K | SEC ↗ | |
| Oct 30, 2026 | 8,804 | $26.27 | $231.3K | SEC ↗ | |
| Oct 29, 2026 | 1,000 | $26.33 | $26.3K | SEC ↗ | |
| Oct 28, 2026 | 10,570 | $25.23 | $266.7K | SEC ↗ | |
| Oct 28, 2026 | 4,430 | $25.97 | $115.0K | SEC ↗ | |
| Oct 27, 2026 | 31,067 | $26.84 | $833.8K | SEC ↗ | |
| Oct 27, 2026 | 8,729 | $25.84 | $225.6K | SEC ↗ | |
| Oct 26, 2026 | 8,261 | $26.97 | $222.8K | SEC ↗ | |
| Oct 26, 2026 | 1,944,444 | $18.00 | $35.0M | SEC ↗ | |
| Oct 23, 2026 | 28,379 | $26.11 | $741.0K | SEC ↗ | |
| Oct 23, 2026 | 24,560 | $25.68 | $630.7K | SEC ↗ | |
| Feb 11, 2025 | KALVcluster | 26,703 | $9.18 | $245.1K | SEC ↗ |
| Feb 7, 2025 | KALVcluster | 73,649 | $9.29 | $684.2K | SEC ↗ |
Follow new qualifying clusters involving Venrock Healthcare Capital Partners III, L.P. or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Venrock Healthcare Capital Partners III, L.P.'s Form 4 filings on SEC EDGAR (CIK 1738048) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.